Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

被引：0

作者：

Lee, Guinevere Q. ^{[1
,2
,3
]}

McCluskey, Suzanne ^{[2
,3
]}

Boum, Yap ^{[4
]}

Hunt, Peter W. ^{[5
]}

Martin, Jeffrey N. ^{[6
]}

Bangsberg, David R. ^{[7
]}

Gao, Xiaojiang ^{[8
]}

Harrigan, P. Richard ^{[1
]}

Haberer, Jessica E. ^{[2
]}

Siedner, Mark J. ^{[4
]}

机构：

[1] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada

[2] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA

[3] Harvard Med Sch, Harvard Univ Ctr AIDS Res, Boston, MA 02115 USA

[4] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda

[5] Univ Calif San Francisco, HIV AIDS Div, San Francisco, CA 94143 USA

[6] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA

[7] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR USA

[8] NCI, Ctr Canc Res, Frederick, MD 21701 USA

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2017年 / 76卷 / 02期

基金：

美国国家卫生研究院;

关键词：

Uganda; Africa; HIV; antiretroviral therapy; HLA-B*57:01; abacavir; INITIATING ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; T-CELL RECOVERY; DRUG-RESISTANCE; MYOCARDIAL-INFARCTION; HYPERSENSITIVITY REACTION; NAIVE INDIVIDUALS; CONTROLLED-TRIAL; ZIDOVUDINE; EFAVIRENZ;

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Despite a poor toxicity profile, zidovudine supersedes abacavir (ABC) as an alternative first-line agent in most international treatment guidelines because of concerns about HLA-B*57:01-related ABC-hypersensitivity. We detected one case of HLA-B*57:01 carriage among 513 HIV-infected individuals in Uganda, which, in combination with previous reports, supports the safety of ABC in the region.

引用

页码：188 / 192

页数：5

共 48 条

[1]

[Anonymous], 2016, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents

[2]

[Anonymous], UNT WEB ANT PRIC RED

[3]

[Anonymous], GUID CLIN MAN TREATM

[4]

[Anonymous], 2013, ADD NAT ANT TREATM G

[5] Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients - 144-week analysis [J].

Arribas, Jose R. ;

Pozniak, Anton L. ;

Gallant, Joel E. ;

DeJesus, Edwin ;

Gazzard, Brian ;

Campo, Rafael E. ;

Chen, Shan-Shan ;

McColl, Damian ;

Holmes, Charles B. ;

Enejosa, Jeffrey ;

Toole, John J. ;

Cheng, Andrew K. .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) :74-78

[6] Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update [J].

Bennett, Diane E. ;

Camacho, Ricardo J. ;

Otelea, Dan ;

Kuritzkes, Daniel R. ;

Fleury, Herve ;

Kiuchi, Mark ;

Heneine, Walid ;

Kantor, Rami ;

Jordan, Michael R. ;

Schapiro, Jonathan M. ;

Vandamme, Anne-Mieke ;

Sandstrom, Paul ;

Boucher, Charles A. B. ;

van de Vijver, David ;

Rhee, Soo-Yon ;

Liu, Tommy F. ;

Pillay, Deenan ;

Shafer, Robert W. .

PLOS ONE, 2009, 4 (03)

[7] Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection:: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903 [J].

Berenguer, Juan ;

Gonzalez, Juan ;

Ribera, Esteban ;

Domingo, Pere ;

Santos, Jesus ;

Miralles, Pilar ;

Ribas, M. Angels ;

Asensi, Victor ;

Gimeno, Juan Luis ;

Antonio Perez-Molina, Jose ;

Alberto Terron, Jose ;

Miguel Santamaria, Juan ;

Pedrol, Enric .

CLINICAL INFECTIOUS DISEASES, 2008, 47 (08) :1083-1092

[8]

Bogner JR, 2001, J ACQ IMMUN DEF SYND, V27, P237, DOI 10.1097/00126334-200107010-00004

[9] The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T-Cell Recovery, and Mortality Among HIV-Infected Ugandans Initiating Antiretroviral Therapy [J].

Byakwaga, Helen ;

Boum, Yap, II ;

Huang, Yong ;

Muzoora, Conrad ;

Kembabazi, Annet ;

Weiser, Sheri D. ;

Bennett, John ;

Cao, Huyen ;

Haberer, Jessica E. ;

Deeks, Steven G. ;

Bangsberg, David R. ;

McCune, Joseph M. ;

Martin, Jeffrey N. ;

Hunt, Peter W. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (03) :383-391

[10] Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings [J].

Campbell, Thomas B. ;

Smeaton, Laura M. ;

Kumarasamy, N. ;

Flanigan, Timothy ;

Klingman, Karin L. ;

Firnhaber, Cynthia ;

Grinsztejn, Beatriz ;

Hosseinipour, Mina C. ;

Kumwenda, Johnstone ;

Lalloo, Umesh ;

Riviere, Cynthia ;

Sanchez, Jorge ;

Melo, Marineide ;

Supparatpinyo, Khuanchai ;

Tripathy, Srikanth ;

Martinez, Ana I. ;

Nair, Apsara ;

Walawander, Ann ;

Moran, Laura ;

Chen, Yun ;

Snowden, Wendy ;

Rooney, James F. ;

Uy, Jonathan ;

Schooley, Robert T. ;

De Gruttola, Victor ;

Hakim, James Gita .

PLOS MEDICINE, 2012, 9 (08)

← 1 2 3 4 5 →